General Information
NuSirt Biopharma DM2 NS-0100-01E
An Extension of Protocol NS-0100-01 to Evaluate the Safety and Effect of Various Fixed-Dose Leucine and Metformin Combinations (NS-0100) Versus Standard Metformin Monotherapy on Glycemic Control in Subjects with Type 2 Diabetes
| Protocol | NS-0100-01E |
|---|---|
| Identifier | NS-0100-01E Site Number: 08 |
| UID | b072e33c-2e7a-4b78-bc79-0fbd6aa772de |
| Status | Done - Archived |
| Phase | 2A |
| Category | Diabetes Type 2 |
| Launch Year | 2014 |
| NCT Number | - |
| Created | 2014-06-27 17:15 |
| Last Updated | 2014-06-27 17:15 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2015-05-12 | No |
| Enrollment Open | 2014-10-24 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2014-08-11 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2016-05-12 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Moon, Mia | MMoon | No |
| Recruiter | Miss, Salomon | SMiss | No |
| Coordinator | Valenzuela, Louisito | LValenzuela | No |
| Regulatory | - | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | NuSirt BioPharma |
|---|---|
| Division | NuSirt BioPharma |
| Team | NuSirt BioPharma |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
